Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
07/2002
07/25/2002WO2002014489A3 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
07/25/2002WO2001094413A3 B7-related nucleic acids and polypeptides and their uses for immunomodulation
07/25/2002WO2001070798A3 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
07/25/2002WO2001032186A3 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule
07/25/2002WO2001015676A3 Compositions and methods for modulating hdl cholesterol and triglyceride levels
07/25/2002WO2001009187A9 Human monoclonal antibodies to her2/neu
07/25/2002WO2001001150A9 Diagnostic test for thrombotic or thromboembolic disease
07/25/2002US20020100069 Treating heart defects; obtain tissue, incubate with modulator of transcription, evaluate tissue for defect
07/25/2002US20020100065 Generating human organs of preferential classification; obtain fetus, graft stem cells into fetal environment, recover hybrid organ, recover organ
07/25/2002US20020098540 Novel polypeptides, and nucleic acids encoding the same
07/25/2002US20020098201 Novel myxoma genes for immune modulation
07/25/2002US20020098167 Administration of stem cells with cytokines
07/25/2002US20020096123 Integrated herd management system utilizing isolated populations of X-chromosome bearing and Y-chromosome bearing spermatozoa
07/25/2002DE10102337A1 Preparing ester containing polyunsaturated fatty acids, useful e.g. in animal or human nutrition, by transforming organism with desaturase gene from Phaeodactylum tricornatum
07/25/2002CA2435081A1 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs
07/25/2002CA2434803A1 Screens and assays for agents useful in controlling parasitic nematodes
07/25/2002CA2434802A1 Isolating cells expressing secreted proteins
07/25/2002CA2434099A1 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes
07/25/2002CA2432800A1 Regulated activation of cell-membrane receptors by metal-chelating agonists
07/24/2002EP1225183A2 Human G-protein coupled receptor
07/24/2002EP1224862A1 Model animal of mesangial cell proliferative nephritis
07/24/2002EP1224861A1 Animal with the mass expression of human gene and test method by using the animal
07/24/2002EP1224291A1 Multiple sclerosis-related superantigen
07/24/2002EP1224268A1 Methods for using 22045, a human cyclic nucleotide phosphodiesterase
07/24/2002EP1224199A1 Transgenic mice containing trp gene disruptions
07/24/2002EP1223937A2 Gene necessary for striatal function, uses thereof, and compounds for modulating same
07/24/2002EP1223852A1 Animal health diagnosis
07/24/2002EP1223802A2 Development of an effective gene transfer technique for introducing foreign dna into sperm cells
07/24/2002CN1360633A Fucosyl transferase gene
07/24/2002CN1359730A Animal nipple degerming agent and method for improving germ environment
07/23/2002US6423693 Growth hormone releasing hormone expression system and methods of use, including use in animals
07/23/2002US6423527 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
07/23/2002US6423521 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/23/2002US6423316 Anticoagulant fusion protein anchored to cell membrane
07/23/2002US6422174 Mixture of bacillus and monosaccharide in aqueous solution
07/23/2002CA2365997A1 Novel polypeptide
07/18/2002WO2002055674A1 Activation of nuclear transfer embryos
07/18/2002WO2002055666A2 Method for identifying genes involved in cell proliferation
07/18/2002WO2002054856A1 Chemical inhibitors of mismatch repair
07/18/2002WO2002044422A8 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits
07/18/2002WO2002028164A3 Cloning endangered and extinct species
07/18/2002WO2002022776A3 Human coagulation factor vii variants
07/18/2002WO2002013758A3 System for regulating in vivo the expression of a transgene by conditional inhibition
07/18/2002WO2002004020A3 Pathogen resistance in organisms
07/18/2002WO2001094951A3 Inhibitors of c-reactive protein induced inflammation
07/18/2002WO2001087980A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
07/18/2002WO2001085798A3 Human monoclonal antibodies to dendritic cells
07/18/2002WO2001083749A3 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
07/18/2002WO2001079468A3 Drug metabolizing enzymes
07/18/2002WO2001072822A3 Genes involved in intestinal inflammatory diseases and use thereof
07/18/2002WO2001068705A3 Il-17 receptor like molecules and uses thereof
07/18/2002WO2001049856A3 Drosophila enzymes, encoding nucleic acids and methods of use
07/18/2002WO2000076310A9 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
07/18/2002US20020095692 Viral polypeptide for use in the treatment and prevention of viral diseases
07/18/2002US20020095691 Method of assaying modulators of hypertension
07/18/2002US20020095024 B7-related nucleic acids and polypeptides useful for immunomodulation
07/18/2002US20020094967 Polynucleotide
07/18/2002US20020094954 Nucleic acids comprising the neuregulin-1-associated gene 1 (NRG1AG1)
07/18/2002US20020094551 T2R taste receptors and genes ecncoding same
07/18/2002DE10136702A1 System zur zell- und entwicklungsspezifischen Selektion differenzierender embryonaler Stammzellen, adulter Stammzellen und embryonaler Keimbahnzellen System for cell and developmental selection differentiating embryonic stem cells, adult stem cells and embryonic germ cells
07/18/2002CA2434926A1 Chemical inhibitors of mismatch repair
07/18/2002CA2434394A1 Activation of nuclear transfer embryos
07/18/2002CA2433739A1 Method for identifying genes involved in cell proliferation
07/17/2002EP1222854A1 Prevention and treatment of diseases associated with blood coagulation
07/17/2002EP1222466A2 Method to identify compounds which modulate fra-1 expression fils
07/17/2002EP1222314A1 Human antibodies
07/17/2002EP1222301A2 Protein production system
07/17/2002EP1222284A2 22196, a novel human aminopeptidase
07/17/2002EP1222282A1 The beta-barrel of the lipid body lipoxygenase
07/17/2002EP1222266A2 Pca3 messenger rna species in benign and malignant prostate tissues
07/17/2002EP1222262A1 Conditional gene trapping construct for the disruption of genes
07/17/2002EP1222226A1 Highly-neutralized ethylene copolymers and their use in golf balls
07/17/2002EP1222206A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto
07/17/2002EP1222205A1 POLYNUCLEOTIDES ENCODING HUMAN AND MURINE ADHESION PROTEINS (BIgR)
07/17/2002EP1222204A1 A DNA MOLECULE ENCODING A VARIANT $g(a) 2B?-ADRENOCEPTOR PROTEIN, AND USES THEREOF
07/16/2002US6420532 Binding to human y2 receptors and expression
07/16/2002US6420150 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
07/16/2002US6420135 Streptococcus pneumoniae polynucleotides and sequences
07/16/2002US6420124 KVLQT1—a long qt syndrome gene
07/11/2002WO2002053775A2 Identification of genetic determinants of polymorphic cyp3a5 expression
07/11/2002WO2002053740A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
07/11/2002WO2002053717A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/11/2002WO2002053710A1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene
07/11/2002WO2002053596A2 Antibodies to insulin-like growth factor i receptor
07/11/2002WO2002053179A1 The method for the production of the egg containing anti-pathogenic bacteria specific antibodies (igy) and the yogurt and ice cream contaiing the igy
07/11/2002WO2002052930A2 Control of sex determination in mammals
07/11/2002WO2002023983A8 Method of producing non-human mammals
07/11/2002WO2002022783A3 Liver gene expression associated with the inhibition of hbv replication or transcription
07/11/2002WO2002010199A3 C3b/c4b complement receptor-like molecules and uses thereof
07/11/2002WO2001079445A3 Pluripotent cells comprising allogenic nucleus and mitochondria
07/11/2002WO2001043540A3 Methods for producing transgenic animals
07/11/2002WO2001019857A3 Facilitative transporter (ft1 and ft2) from drosophila melanogaster and uses thereof
07/11/2002WO2000067016A9 Methods for the identification of compounds for the treatment of alzheimer's disease
07/11/2002WO2000066179A9 Noninvasive genetic immunization, expression products therefrom, and uses thereof
07/11/2002WO2000062067A9 Novel transduction molecules and methods for using same
07/11/2002US20020092035 Cell cultures for use in monitoring preferential gene expression in cells
07/11/2002US20020092033 Turn animal bladder into a bioreactor, for gene expression of any exogenous biomolecule such as blood clotting factors, hormones; also animal models of bladder cancer; easy to purify from urine
07/11/2002US20020090363 Sustained bioactive agent delivery device and methods of making and using the same
07/11/2002CA2433800A1 Antibodies to insulin-like growth factor i receptor
07/11/2002CA2433559A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof